General Dermatology

Translational Takeaways distills the most clinically relevant findings from emerging dermatology research into clear, practice-focused insights that inform real-world decision-making.

Can a Mediterranean diet clear skin, or is it just a myth? Read more about the latest social media trend and learn how to counsel your patients in the clinic.

Data show that upadacitinib reduces systemic inflammatory burden in AD, including hs-CRP, a biomarker validated as an independent predictor of major cardiovascular events.

Learn how a specialized financial partner can enable independent practices to navigate market pressures while expanding access and boosting performance.

Recent research on orchid-derived skin care reveals antioxidant, anti-inflammatory, and wound-healing potential, but major gaps in clinical proof and safety reporting remain.

Turmeric and curcumin supplements used for hair loss are increasingly associated with rare but serious cases of liver injury.

Cold atmospheric plasma eases stubborn oral lichen planus in long follow-up study, with a new scoring system tracking pain, function, and healing.

The high-dose D-MNA cohort showed continued improvement from Day 29 to Day 57, a trajectory not observed in the device-only control arm, supporting a drug-driven mechanism of action.

The case underscores that classic imaging hallmarks of necrotizing fasciitis are frequently absent in early-stage disease, making a high index of clinical suspicion essential for front-line providers.

Are at-home red light LED masks just a myth? Read more about the latest social media trend and discover how you should counsel your patients in the clinic.

An early look at the finalized print issue—featuring key data, clinical takeaways, and expert insights before it reaches your mailbox.

Dermatology Times is looking back on the top stories in dermatology from the month of April.

This month’s podcasts highlight the latest clinical insights, emerging therapies, and evolving conversations shaping dermatology practice.

Learn more about the in-depth topics covered in the April 2026 print issue of Dermatology Times.

Explore the top headlines of the month, including insights on the latest clinical trials, therapeutic updates, and more.

A systematic review of 8 studies finds early evidence for microneedling plus exosome therapy across alopecia, aging, pigmentation, and scarring, but calls for larger trials.

The deal would vault the combined company to 7th-largest biosimilar player globally, with direct implications for biologic access in dermatology.

Combination therapy may be particularly beneficial for frontal hairline regrowth, a traditionally difficult area to treat.

The FDA has accepted the resubmitted BLA for relabotulinumtoxinA, a next-generation neuromodulator for treating facial lines in adults.

In case you missed it, this week we had news on the approval of dupilumab for pediatric CSU, phase 2b hair growth results with rezpegaldesleukin, multispecific biologics for AD, and more.

At the 2026 Winter Clinical Miami meeting, dermatology leaders emphasized that thriving careers require skills beyond clinical expertise.

Renal transplant patients face frequent warts, fungal infections, and steroid acne, according to new 10-year data.

Although microbes inhabit many body sites, the skin is one of the most densely populated areas after the gastrointestinal tract.

A meta-analysis cited in the review found depression prevalence among melasma patients at 43.4% — approximately 12 times the estimated global rate — highlighting the psychiatric weight of pregnancy-associated skin changes.

Explore the top headlines of the week, including insights on the latest clinical trials, therapeutic updates, and more.